Tag: Vasomune
-
Vasomune expands with AnGes partnership to broaden vascular damage therapy indications
Vasomune and AnGes announce expanded collaboration The Sunnybrook-based start-up Vasomune Therapeutics has strengthened its strategic alliance with Japanese biopharma company AnGes. The expanded partnership aims to broaden the indications for Vasomune’s lead drug candidate, which targets vascular damage and related cardiovascular conditions. The agreement comes with a $4 million funding commitment designed to accelerate development…
-
Vasomune Expands Partnership with AnGes to Advance Vascular Damage Drug Candidate
Overview: A Strategic Expansion in Vascular Therapy Sunnybrook-based startup Vasomune Therapeutics is broadening its collaboration with pharmaceutical giant AnGes to expand the indications for their leading drug candidate designed to treat vascular damage. The new agreement injects $4 million in funding to accelerate development, clinical milestones, and regulatory progress as the two companies pursue improved…
-
Vasomune and AnGes Expand Vascular Drug Indications Partnership
Partnership Overview Sunnybrook-based start-up Vasomune Therapeutics has announced an expanded collaboration with the Japanese biopharma company AnGes to broaden the indications for their vascular damage treatment candidate. The agreement will extend the reach of the collaboration beyond its initial scope, enabling further development and validation across additional vascular conditions. The expanded partnership comes with a…